Drug & medication recalls Moderate risk

SEMAGLUTIDE 10mg/ recalled over sterility concerns

Recall date
August 22, 2024
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
ProRx LLC recalls SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 8…
Recall number
D-0653-2024
FDA classification
Class II
Brand / firm
ProRx LLC
Sold / distributed
Nationwide in the USA

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-04

Get recall alerts

Free email alert whenever ProRx LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: ProRx LLC